Immune responses of pigs to commercialized emulsion FMD vaccines and live virus challenge.
The immune response to structural and non-structural proteins (NSPs) was studied on sequential serum samples in swine from O/Taiwan/97 FMDV challenge studies, outbreaks and after vaccination. The results showed that pigs vaccinated with a commercial vaccine prior to or after infection maintained high neutralizing antibody titers with gradual decline from peak titers over the duration of this study. However, neutralizing antibody titers in non-vaccinated pigs only reached moderate levels 2-4 weeks post infection and remained low thereafter. For the 3B and 3ABC NSP antibody ELISA responses, there were gradually decreasing levels of NSP antibody over time. In multiple vaccinations, all pigs showed significant increases in neutralizing antibodies after booster vaccination. For the 3B NSP antibody ELISA after vaccination, the mean S/P ratios for pigs vaccinated with all three FMD vaccines were all below the 0.23 cut-off value set by the manufacture, but some sera from individual vaccinated pigs gave results above this cut-off after primary or secondary vaccination. However, with the 3ABC NSP antibody ELISA, all sera from vaccinated pigs had negative results for NSP antibody for all time points.
Chen
S P
SP
Division of Animal Medicine, Animal Technology Institute Taiwan, Chunan, Miaoli, Taiwan.
Lee
M C
MC
Sun
Y F
YF
Cheng
I C
IC
Yang
P C
PC
Lin
Y L
YL
Jong
M H
MH
Robertson
I D
ID
Edwards
J R
JR
Ellis
T M
TM
D000818:Animals; D000914:Antibodies, Viral / Q000097:blood*; D004196:Disease Outbreaks / Q000662:veterinary; D004655:Emulsions / Q000008:administration & dosage; D005536:Foot-and-Mouth Disease / Q000453:epidemiology / Q000276:immunology / Q000517:prevention & control* / Q000821:virology; D029544:Foot-and-Mouth Disease Virus / Q000276:immunology* / Q000472:pathogenicity*; D009500:Neutralization Tests; D013552:Swine; D013553:Swine Diseases / Q000453:epidemiology / Q000276:immunology / Q000517:prevention & control* / Q000821:virology; D013624:Taiwan / Q000453:epidemiology; D014611:Vaccination / Q000662:veterinary; D017361:Viral Nonstructural Proteins / Q000276:immunology; D015678:Viral Structural Proteins / Q000276:immunology; D014765:Viral Vaccines / Q000008:administration & dosage / Q000276:immunology*
D000914:Antibodies, Viral; D004655:Emulsions; D017361:Viral Nonstructural Proteins; D015678:Viral Structural Proteins; D014765:Viral Vaccines